Conavi Medical Corp. (TSXV:CNVI)

Conavi Medical Statistics

Total Valuation

Conavi Medical has a market cap or net worth of CAD 45.28 million. The enterprise value is 54.01 million.

Market Cap	45.28M
Enterprise Value	54.01M

Important Dates

The next estimated earnings date is Friday, December 19, 2025.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Conavi Medical has 76.75 million shares outstanding. The number of shares has increased by 545.55% in one year.

Current Share Class	76.75M
Shares Outstanding	76.75M
Shares Change (YoY)	+545.55%
Shares Change (QoQ)	+54.88%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	0.00%
Float	42.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.90
PB Ratio	-3.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.81
EV / Sales	5.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.18

Financial Position

The company has a current ratio of 2.14

Current Ratio	2.14
Quick Ratio	1.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-1.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.95%
Return on Invested Capital (ROIC)	-240.62%
Return on Capital Employed (ROCE)	-140.05%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.66
Inventory Turnover	1.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-48.70%
50-Day Moving Average	0.53
200-Day Moving Average	0.54
Relative Strength Index (RSI)	49.63
Average Volume (20 Days)	30,077

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Conavi Medical had revenue of CAD 9.24 million and -29.81 million in losses. Loss per share was -0.75.

Revenue	9.24M
Gross Profit	7.33M
Operating Income	-15.99M
Pretax Income	-29.81M
Net Income	-29.81M
EBITDA	-15.54M
EBIT	-15.99M
Loss Per Share	-0.75

Balance Sheet

The company has 11.28 million in cash and 20.01 million in debt, giving a net cash position of -8.73 million or -0.11 per share.

Cash & Cash Equivalents	11.28M
Total Debt	20.01M
Net Cash	-8.73M
Net Cash Per Share	-0.11
Equity (Book Value)	-11.79M
Book Value Per Share	-0.15
Working Capital	7.15M

Cash Flow

In the last 12 months, operating cash flow was -24.59 million and capital expenditures -221,000, giving a free cash flow of -24.81 million.

Operating Cash Flow	-24.59M
Capital Expenditures	-221,000
Free Cash Flow	-24.81M
FCF Per Share	-0.32

Margins

Gross Margin	79.35%
Operating Margin	-173.12%
Pretax Margin	-322.74%
Profit Margin	n/a
EBITDA Margin	-168.28%
EBIT Margin	-173.12%
FCF Margin	n/a

Dividends & Yields

Conavi Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-545.55%
Shareholder Yield	-545.55%
Earnings Yield	-65.83%
FCF Yield	-54.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

Conavi Medical has an Altman Z-Score of -13.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.99
Piotroski F-Score	4